Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **general receptor for phosphoinositides 1-associated scaffold protein (TAMALIN)** is a neuronal molecular scaffold protein highly expressed in the brain, especially in the telencephalon[1][2]. TAMALIN contains a leucine zipper, PDZ domain, and a C-terminal PDZ-binding motif, allowing it to interact with diverse binding partners[2][4]. It regulates the trafficking of group I metabotropic glutamate receptors (mGluR1, mGluR5) to the cell surface by switching between autoinhibited and active conformations via its PDZ domain[1][3]. Moreover, TAMALIN (GRASP) anchors multiprotein signaling complexes that control small GTPase crosstalk, particularly by directly bridging cytohesin 2/ARNO and Dock180, which coordinate the activities of Arf6 and Rac1 and facilitate epithelial cell migration in response to growth factors[4]. TAMALIN therefore plays a central role in neuronal signaling, receptor trafficking, and cellular morphological changes, but is not currently a direct therapeutic target or drug receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General receptor for phosphoinositides 1-associated scaffold protein (TAMALIN).